With now over fifty years of packaging expertise and in excess of 50 successful product launches per year, PCI is a trusted leader and industry expert in the commercialization of new medicines.
Our global capabilities include packaging for large-scale projects requiring sophisticated integrated technologies and automation and the support of more targeted therapies for select patient populations.
EU Serialization & Anti-counterfeiting Update
DEADLINE FOR COMPLIANCE: FEBRUARY 9TH 2019
We are industry leaders in product security for global medicines with significant Serialization and Anticounterfeiting technologies. Find out how our experienced teams can work with you to understand your exact requirements to ensure your product’s integrity and protect patient safety.
Our insights and expertise enable us to provide packaging solutions that truly differentiate products. We deliver product to patients creatively and effectively meeting the varying needs of each customer and market that we serve. We adapt to the unique requirements of each global market, from Brand and Generic Ethical pharmaceuticals and Biotech medicines, Over-the-Counter pharmaceuticals, Consumer Healthcare products, as well as specialized requirements for Medical Devices and Specialty Products. Our exemplary regulatory compliance record combined with our expertise in international legislative requirements ensures that we offer a best-in-class service of each and every customer.
We support global commercial supply with ongoing investment in state-of-the-art facilities and advanced packaging technologies along with a dedicated workforce focused on delivering a consistently reliable and outstanding performance.
Packaging types supported include:
- Labeling for Parenterals and Injectables
- Tyvek Blistering for Parenterals
- Device Assembly including
- Autoinjectors and Pens
- Child Resistant and Compliance Prompting Packaging
- Overwrapping and Pouching
Our dedicated team of specialists will be happy to discuss any of your Commercial Packaging needs. Contact us on +1 779-774-1428 (US) or +44 1495 713 633 (UK) or email email@example.com
PCI is pleased to welcome Serge Dupuis as Senior Vice President and Chief Financial Officer. Serge’s appointment supports PCI’s continued... View Article
PCI will share our specialist clinical trials expertise at the upcoming Clinical Trial Supply New England Conference. PCI’s Jeremy Osborne,... View Article